Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03418857 · ClinicalTrials.gov registry record · Phase 1

Probiotics and Gut Health

A Phase 1 study of Metabolic Syndrome, sponsored by Penn State University.

Recruiting
Registry status
Phase 1
Development phase
40
Enrollment target
1
Study location

NCT03418857 is a Phase 1 study of Metabolic Syndrome that is actively recruiting participants, run by Penn State University. The registered enrollment target is 40 participants, below the 1,205-participant average among 102 other Metabolic Syndrome trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03418857, a Phase 1 study of Metabolic Syndrome, is actively recruiting participants, sponsored by Penn State University.

RECRUITING
Registry status
Phase 1
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

This study evaluates the effects of probiotic consumption on inflammatory outcomes and measures of gut health. Participants will be given yogurt with probiotics for one period and yogurt without probiotics for another, with a break in between. These periods will occur in random order.

Conditions Studied

Interventions

  • DRUG Yogurt smoothie with BB-12
  • DRUG Yogurt smoothie

Study Locations (1)

Pennsylvania

  • The Pennsylvania State University - University Park

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2018-06-29
Est. Completion 2022-12
Phase Phase 1

Sponsor

Penn State University

219 total trials

What the Registry Record Tells You About NCT03418857

The ClinicalTrials.gov registry entry for NCT03418857 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,205-participant average among 102 other Metabolic Syndrome trials with a reported enrollment target (97% lower). The listed sponsor is Penn State University, which has 219 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Metabolic Syndrome appearing as the primary indexed condition, and to 2 interventions - of which Yogurt smoothie with BB-12 is the first listed.

NCT03418857 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT03418857 about?

NCT03418857 is a clinical study titled "Probiotics and Gut Health". This study evaluates the effects of probiotic consumption on inflammatory outcomes and measures of gut health. Participants will be given yogurt with probiotics for one period and yogurt without probiotics for another, with a break in between. These periods will occur in random order.

What is the current status of trial NCT03418857?

This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 40 participants. The study started on 2018-06-29. Estimated completion is 2022-12.

What conditions does trial NCT03418857 study?

This clinical trial studies the following conditions: Metabolic Syndrome.

What interventions are being tested in trial NCT03418857?

The interventions under investigation include: Yogurt smoothie with BB-12 (DRUG), Yogurt smoothie (DRUG).

Who is sponsoring clinical trial NCT03418857?

This trial is sponsored by Penn State University, which has 219 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03418857 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Metabolic Syndrome

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.